Zometa 4mg Intravenous Injection Vial from Japan
Zometa is a sterile lyophilized powder containing 4mg of zoledronic acid for reconstitution and intravenous administration to treat hypercalcemia of malignancy and bone metastases. It falls under HTS 3004.90.92.75 as a mixed or unmixed medicament put up in measured doses for therapeutic use, specifically containing zoledronic acid. This classification applies to its retail-packed form for oncology and palliative care.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA import approval and ensure NDC labeling compliance prior to shipment; verify cold chain logistics to maintain potency during transit; declare exact measured dose and active ingredient concentration to avoid reclassification